Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith the intimation dated 10th April, 2024 received from our RTA.
10-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find attached the certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
09-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Please find attached herewith the Postal Ballot Notice.
09-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the Copy of Newspaper Publication dated 8th April, 2024.
08-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30

Kindly find attached herewith the Intimation under Regulation 30 of SEBI LODR, Regulations 2015.
08-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliance Certificate For The Financial Year Ended 31St March, 2024

Please find attached herewith the Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR Regulations, 2015 for the Financial Year ended March 31, 2024.
08-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Alembic Global Holding SA, WOS of Alembic Pharmaceuticals Limited has subscribed in New entity TicTwo Therapeutics Inc.
05-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

The Company has received two orders from Office of Assistant Commissioner of Central GST and Central Excise, Vadodara, imposing penalty.
04-04-2024

Alembic Pharma Gets Tentative USFDA Nod For Breast Cancer Drug

Alembic Pharma receives tentative USFDA approval for generic Ribociclib tablets, used in the treatment of breast cancer.
01-04-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith the intimation received from our RTA dated 1st April, 2024.
01-04-2024
Next Page
Close

Let's Open Free Demat Account